The Enterprise Value as of November 2025 (TTM) for The Valens Company Inc. (VLNS) is -670000.00

According to The Valens Company Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -670000.00. This represents a change of -100.74% compared to the average of 91.07M of the last 4 quarters.

The Valens Company Inc. (VLNS) Historical Enterprise Value (quarterly & annually)

How has VLNS Enterprise Value performed in the past?

The mean historical Enterprise Value of The Valens Company Inc. over the last ten years is 12.80M. The current -670000.00 Enterprise Value has changed -623.60% with respect to the historical average. Over the past ten years (40 quarters), VLNS's Enterprise Value was at its highest in in the August 2022 quarter at 119.65M. The Enterprise Value was at its lowest in in the May 2019 quarter at -21233797.94.

The Valens Company Inc. (VLNS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of The Valens Company Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

The Valens Company Inc. (VLNS) Average Enterprise Value

How has VLNS Enterprise Value performed in the past?

The current Enterprise Value of The Valens Company Inc. (VLNS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

The Valens Company Inc. (VLNS) Enterprise Value vs. Peers

How is VLNS’s Enterprise Value compared to its peers?

The Valens Company Inc.’s Enterprise Value is less than DURECT Corporation (54.56M), greater than Reneo Pharmaceuticals, Inc. (-21710584.00), less than Zynerba Pharmaceuticals, Inc. (19.81M), greater than Achilles Therapeutics plc (-21604000.00), greater than NeueHealth, Inc. (-69677307.00), less than Chicago Atlantic BDC, Inc. (780.90M), less than Akoya Biosciences, Inc. (127.81M), less than Heat Biologics, Inc. (20.56T), less than Bonk, Inc. (29.94M), less than Surface Oncology, Inc. (70.21M),

Build a custom stock screener for The Valens Company Inc. (VLNS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like The Valens Company Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

The Valens Company Inc. (VLNS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like The Valens Company Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.